XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Restatement of Previously Issued Financial Statements, Summary (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Aug. 02, 2022
Dec. 31, 2021
Restatement of Previously Issued Financial Statements [Abstract]            
Prepaid expenses and other current assets $ 4,545   $ 4,545     $ 1,116
Research and development expense 7,507 $ 6,313 21,799 $ 19,268    
Receivable research incentives 183   183     4,774
Trade accounts receivable, net 419   419     421
Deferred revenue, current 1,668   1,668     2,665
Operating expenses 16,205 10,793 41,347 31,074    
Additional paid-in capital 370,155   370,155     148,850
General and administrative 5,925 2,801 13,566 7,831    
Sales and marketing 2,773 1,679 5,982 3,975    
Cost of revenue 654 307 1,858 873    
Retained earning (364,008)   (364,008)     (325,268)
Loans payable, noncurrent 12,626   12,626     12,233
Interest expense 1,069 $ 205 3,588 $ 590    
Trade accounts payable 2,487   2,487     2,109
Previously Reported [Member]            
Restatement of Previously Issued Financial Statements [Abstract]            
Prepaid expenses and other current assets 8,190   8,190      
Research and development expense 7,334   20,933      
Receivable research incentives 1,052   1,052      
Trade accounts receivable, net 740   740      
Deferred revenue, current 1,989   1,989      
Operating expenses 16,354   40,898      
Additional paid-in capital 372,840   372,840      
General and administrative 6,921   14,527      
Sales and marketing 2,099   5,438      
Cost of revenue 609   1,778      
Retained earning (363,136)   (363,136)      
Loans payable, noncurrent 12,912   12,912      
Interest expense 1,336   3,874      
Trade accounts payable 3,158   3,158      
Adjustment [Member]            
Restatement of Previously Issued Financial Statements [Abstract]            
Prepaid expenses and other current assets (3,645)   (3,645)      
Research and development expense 173   866      
Receivable research incentives (869)   (869)      
Trade accounts receivable, net (321)   (321)      
Deferred revenue, current (321)   (321)      
Operating expenses (149)   449      
Additional paid-in capital (2,685)   (2,685)      
General and administrative (996)   (961)      
Sales and marketing 674   544      
Cost of revenue 45   80      
Retained earning (872)   (872)      
Loans payable, noncurrent (286)   (286)      
Interest expense (267)   (286)      
Trade accounts payable (671)   (671)      
Error in Accounting for Lincoln Park Purchase Agreement [Member]            
Restatement of Previously Issued Financial Statements [Abstract]            
Contractual liability         $ 2,700  
Aggregate fair value of commitment shares     3,300      
Post merger expense     1,900      
Error in Accounting for Lincoln Park Purchase Agreement [Member] | Previously Reported [Member]            
Restatement of Previously Issued Financial Statements [Abstract]            
Fair value of equity-classified Purchase Agreement     0      
Prepaid expenses and other current assets 3,300   3,300      
Error in Accounting for Scientific Research and Experimental Development ("SR&ED") Receivable [Member] | Previously Reported [Member]            
Restatement of Previously Issued Financial Statements [Abstract]            
Research and development expense (100)   (900)      
Receivable research incentives 900   900      
Error in Accounting for Deferred Revenue [Member]            
Restatement of Previously Issued Financial Statements [Abstract]            
Trade accounts receivable, net 400   400      
Deferred revenue, current $ 400   $ 400      
Error in Accounting for Stock-Based Compensation [Member]            
Restatement of Previously Issued Financial Statements [Abstract]            
Share price (in usd per share) $ 10.07   $ 10.07      
Error in Accounting for Stock-Based Compensation [Member] | Previously Reported [Member]            
Restatement of Previously Issued Financial Statements [Abstract]            
Share price (in usd per share) $ 5.72   $ 5.72      
Operating expenses $ 200   $ 300      
Additional paid-in capital (300)   (300)      
Error in Accounting for Stock-Based Compensation [Member] | Adjustment [Member]            
Restatement of Previously Issued Financial Statements [Abstract]            
Research and development expense 31   (3)      
General and administrative (1,000)   (1,000)      
Sales and marketing 700   500      
Cost of revenue 45   $ 80      
Error in Accounting for SIF Interest [Member]            
Restatement of Previously Issued Financial Statements [Abstract]            
Loan repayment term     2 years      
Error in Accounting for SIF Interest [Member] | Previously Reported [Member]            
Restatement of Previously Issued Financial Statements [Abstract]            
Loan repayment term     1 year      
Loans payable, noncurrent 28,000   $ 28,000      
Interest expense 9   28      
Error in Accounting for SIF Interest [Member] | Adjustment [Member]            
Restatement of Previously Issued Financial Statements [Abstract]            
Strategic innovation fund loan           300
Retained earning           $ (300)
Loans payable, noncurrent 300   300      
Error in Accounting for Prepaid Expenses [Member] | Previously Reported [Member]            
Restatement of Previously Issued Financial Statements [Abstract]            
Prepaid expenses and other current assets 500   500      
Trade accounts payable 500   500      
Error in Accounting for Transaction Costs [Member] | Previously Reported [Member]            
Restatement of Previously Issued Financial Statements [Abstract]            
Additional paid-in capital (300)   (300)      
Trade accounts payable $ 300   $ 300